Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(23)00321-2
PubMed Identifier: 38061371
Publication URI: http://europepmc.org/abstract/MED/38061371
Type: Journal Article/Review
Volume: 12
Parent Publication: The lancet. Diabetes & endocrinology
Issue: 1
ISSN: 2213-8587